As of 2025-10-16, the Relative Valuation of Evelo Biosciences Inc (EVLO) is (37.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of Evelo Biosciences Inc based on Relative Valuation is -18758222.0%.
The range of the Relative Valuation is (29.58) - (49.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (29.58) - (49.50) | (37.52) |
| Upside | -14789112.2% - -24749946.8% | -18758222.0% |
| Date | P/E |
| 2025-10-08 | -0.00 |
| 2025-10-07 | -0.00 |
| 2025-10-06 | -0.00 |
| 2025-09-29 | -0.00 |
| 2025-09-26 | -0.00 |
| 2025-09-24 | -0.00 |
| 2025-09-18 | -0.00 |
| 2025-09-03 | -0.00 |
| 2025-08-29 | -0.00 |
| 2025-08-26 | -0.00 |
| 2025-08-21 | -0.00 |
| 2025-08-19 | -0.00 |
| 2025-08-15 | -0.00 |
| 2025-07-31 | -0.00 |
| 2025-07-30 | -0.00 |
| 2025-07-23 | -0.00 |
| 2025-07-21 | -0.00 |
| 2025-07-18 | -0.00 |
| 2025-07-16 | -0.00 |